United States

Multiple Sclerosis Therapeutic Market to hit USD 38.1 billion by 2032, says Global Market Insights Inc.

Multiple sclerosis therapeutic industry is projected to witness a CAGR of 4.7% during the period 2024-2032. This growth can be attributed to increasing prevalence of multiple sclerosis.

Selbyville, Delaware, Sept. 30, 2024 (GLOBE NEWSWIRE) —

Multiple Sclerosis Therapeutic

Major players in multiple sclerosis therapeutic market include Abbvie Inc., Amgen Inc., Acorda Therapeutics, Inc., Biogen Inc., Bayer AG, Bristol-Myers Squibb Company., F. Hoffman-La Roche Ltd. Johnson & Johnson, Merck & Co., Inc., Novartis AG among others.

Partial Table of Contents (ToC) of the report:

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing prevalence of multiple sclerosis

3.2.1.2    Advancements in drug development

3.2.1.3    Growing focus on personalized medicine

3.2.1.4    Rising geriatric population

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost of the drugs

3.2.2.2    Side effects associated with the medication

3.3    Growth potential analysis

3.4    Technology landscape

3.5    Pipeline analysis

3.6    Regulatory landscape

3.7    Future market trends

3.8    Porter’s analysis

3.9    PESTEL analysis

Browse more disease specific drugs industry reports @ https://www.gminsights.com/industry-reports/disease-specific-drugs/82

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

CONTACT: Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: +1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email: [email protected]
Read More News @ https://ibmag.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker